AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2017
May 3, 2017
284_dirs_2017-05-03_99c21a33-a139-4571-9a1d-3705c07c4de0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2017-05-02
Reporting Person: Gerberding Julie L. (EVP Strat Comm, Gl Pub Policy)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-02 | Common Stock | M | 3092.0000 | $0.0000 | Acquired | 46416.3480 | Direct |
| 2017-05-02 | Common Stock | F | 1078.0000 | $62.3800 | Disposed | 45338.3480 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-02 | Restricted Stock Unit | $ | M | 3092.0000 | Disposed | 2017-05-02 | Common Stock (3092.0000) | Direct |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8